Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Castinetti

Showing results (11-20 of 133) with videos related to

Pageof 14
Sort By:
Pituitary|September 8, 2016
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesMaria Fleseriu, Frederic Castinetti
The Journal of Clinical Endocrinology and Metabolism|September 14, 2022
Is Desmopressin Useful in the Evaluation of Cushing Syndrome?Frederic Castinetti, André Lacroix
Endocrine-Related Cancer|October 15, 2024
Genotype/phenotype correlations in multiple endocrine neoplasia type 2Frederic Castinetti, Charis Eng
Nature Reviews. Endocrinology|October 12, 2017
Pituitary gland: Gamma Knife for Cushing disease - time for a reappraisal?Frederic Castinetti, Thierry Brue
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2022
Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now?Frederic Castinetti, Gerald Raverot
The Journal of Clinical Endocrinology and Metabolism|July 15, 2024
Paltusotine: A Step Toward Precision Medicine in AcromegalyFrederic Castinetti, Thierry Brue
Annales D'Endocrinologie|August 1, 2025
Reply to the letter to the editor by Helvaci and Cakal: "Reducing risks in bilateral inferior petrosal sinus sampling: Addressing thromboprophylaxis in Cushing syndrome"Cecilia Piazzola, Frederic Castinetti
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Letter to the Editor: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness"Frederic Castinetti, Nelson Wohllk
Orphanet Journal of Rare Diseases|October 8, 2016
The risks of overlooking the diagnosis of secreting pituitary adenomasThierry Brue, Frederic Castinetti
European Journal of Endocrinology|November 13, 2023
Letter to the Editor from Piazzola and Castinetti: "Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study"Cecilia Piazzola, Frederic Castinetti
Pageof 14

Showing results (11-20 of 133) with videos related to

Sort By:
Pageof 14
Pituitary|September 8, 2016
Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapiesMaria Fleseriu, Frederic Castinetti
The Journal of Clinical Endocrinology and Metabolism|September 14, 2022
Is Desmopressin Useful in the Evaluation of Cushing Syndrome?Frederic Castinetti, André Lacroix
Endocrine-Related Cancer|October 15, 2024
Genotype/phenotype correlations in multiple endocrine neoplasia type 2Frederic Castinetti, Charis Eng
Nature Reviews. Endocrinology|October 12, 2017
Pituitary gland: Gamma Knife for Cushing disease - time for a reappraisal?Frederic Castinetti, Thierry Brue
Best Practice & Research. Clinical Endocrinology & Metabolism|December 2, 2022
Pituitary neuroendocrine tumors: from old treatments to innovations, from efficacy to tolerance, from benignity to carcinomas, where do we stand now?Frederic Castinetti, Gerald Raverot
The Journal of Clinical Endocrinology and Metabolism|July 15, 2024
Paltusotine: A Step Toward Precision Medicine in AcromegalyFrederic Castinetti, Thierry Brue
Annales D'Endocrinologie|August 1, 2025
Reply to the letter to the editor by Helvaci and Cakal: "Reducing risks in bilateral inferior petrosal sinus sampling: Addressing thromboprophylaxis in Cushing syndrome"Cecilia Piazzola, Frederic Castinetti
The Journal of Clinical Endocrinology and Metabolism|September 16, 2017
Letter to the Editor: "Medullary Thyroid Carcinoma in MEN2A: ATA Moderate- or High-Risk RET Mutations Do Not Predict Disease Aggressiveness"Frederic Castinetti, Nelson Wohllk
Orphanet Journal of Rare Diseases|October 8, 2016
The risks of overlooking the diagnosis of secreting pituitary adenomasThierry Brue, Frederic Castinetti
European Journal of Endocrinology|November 13, 2023
Letter to the Editor from Piazzola and Castinetti: "Bilateral inferior petrosal sinus sampling with human CRH stimulation in ACTH-dependent Cushing's syndrome: results from a retrospective multicenter study"Cecilia Piazzola, Frederic Castinetti
Pageof 14